The study will explore the neurocognitive effect of four weeks of treatment with amantadine versus placebo in patients with traumatic brain injury using the Interval Bisection Timing Task. Approximately 16 individuals with traumatic brain injury are expected to participate in this study. Subject participation is expected to last up to 8 weeks with 16 study visits.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
BASIC_SCIENCE
Masking
SINGLE
amantadine twice daily
amantadine 100 mg twice daily
CHS-Behavioral Health Research
Charlotte, North Carolina, United States
The primary outcome measure is the Interval Bisection Timing Task.
Time frame: 12 -16 months
The secondary efficacy measure is the Barrett Impulsiveness Scale (BIS-11).
Time frame: 12-16 moths
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.